Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
Tumor Immunotherapy01:27

Tumor Immunotherapy

476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the epigenetic landscape: transforming renal cell carcinoma treatment.

Clinical epigenetics·2026
Same author

A Dual Photonic Structure with Beaded Networks and Core-Shell Nanoparticles for Ultrathin yet High-Performance Passive Daytime Radiative Cooling Coatings.

ACS applied materials & interfaces·2026
Same author

Predictive value of interstitial inflammation for renal outcome in patients with immunoglobulin a nephropathy.

Immunobiology·2026
Same author

Renal interstitial inflammation predicts IgA nephropathy progression via multiple machine learning models.

Clinical nephrology·2025
Same author

Nephrotic syndrome in a 51-year-old woman with light chain deposition disease.

Ultrastructural pathology·2025
Same author

Renal aging and its consequences: navigating the challenges of an aging population.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Jun 5, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.1K

Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after

Xinxin Luo1, Haifeng Ni1, Jie Lu1

  • 1College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, PR China.

ACS Applied Bio Materials
|December 4, 2024
PubMed
Summary

Degradable zwitterionic cryogels offer a promising cancer vaccine platform. These injectable cryogels enhance immune response and prevent tumor recurrence, showing biocompatibility and sustained antigen release.

Keywords:
cancer vaccinecryogelsdegradableinjectablezwitterionic

More Related Videos

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

7.7K
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.2K

Related Experiment Videos

Last Updated: Jun 5, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.1K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

7.7K
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.2K

Area of Science:

  • Biomaterials Science
  • Immunology
  • Cancer Therapy

Background:

  • Cancer remains a prevalent disease with high recurrence rates despite conventional treatments.
  • Injectable cancer vaccines show promise but often struggle with sustained immune activation.
  • Effective long-term immune surveillance against tumorigenesis requires robust tumor-specific cytotoxic T cell responses.

Purpose of the Study:

  • To develop a novel injectable vaccine platform using degradable zwitterionic cryogels for enhanced cancer prevention and treatment.
  • To investigate the cryogel's ability to maintain antigen and adjuvant activity and facilitate sustained immune cell recruitment.
  • To evaluate the efficacy of cryogel-based cancer vaccines, alone and in combination with photothermal therapy, in preventing tumor recurrence.

Main Methods:

  • Preparation of degradable zwitterionic cryogels via cryogelation technique, incorporating tumor antigens and immune adjuvants.
  • Assessment of cryogel injectability, antigen/adjuvant loading, and sustained release properties in response to protease degradation.
  • Evaluation of in vivo immune activation, tumor microenvironment modulation, and anti-tumor effects, including combination with photothermal therapy.

Main Results:

  • Cryogenic preparation preserved the biological activity of loaded antigens and adjuvants.
  • The macroporous cryogels were injectable and exhibited sustained release of antigens and adjuvants upon degradation.
  • In vivo studies showed robust immune activation, effective tumor microenvironment modulation, and significant tumor growth inhibition, especially when combined with photothermal therapy.
  • Zwitterionic cryogels demonstrated biocompatibility and no obvious toxicity during degradation.

Conclusions:

  • Degradable zwitterionic cryogels serve as an effective and biocompatible platform for cancer vaccines.
  • The cryogel vaccine platform facilitates sustained antigen presentation and robust anti-tumor immune responses.
  • This approach holds significant potential for preventing cancer recurrence, particularly after surgery, and warrants further clinical investigation.